PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) will report fourth quarter and full year 2025 financial results on Thursday, Feb. 19, 2026 at 4:30 p.m. ET. The company will host a webcast conference call to discuss results, business updates, and outlook.

Investors can register for phone access or join the webcast on the company's Investors site. A replay will be archived on the company website for 30 days.

News Market Reaction

-2.10%

1 alert

-2.10% News Effect

On the day this news was published, PTCT declined 2.10%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings call date: Feb. 19, 2026 Earnings call time: 4:30 p.m. ET Replay duration: 30 days

3 metrics

Earnings call date Feb. 19, 2026 Fourth quarter and full year 2025 results

Earnings call time 4:30 p.m. ET Start time of webcast conference call

Replay duration 30 days Webcast replay archived on company website

Market Reality Check

Price: $72.14 Vol: Volume 986,768 vs 20-day ...

normal vol

$72.14 Last Close

Volume Volume 986,768 vs 20-day average 1,310,774 ahead of the earnings call. normal

Technical Trading above 200-day MA, with price 73.91 vs 200-day MA at 60.46.

Peers on Argus

Peers RNA (-0.38%), CRSP (-3.31%), MRUS (-7.08%), TGTX (-2.87%) and KRYS (-4.33%...

Peers RNA (-0.38%), CRSP (-3.31%), MRUS (-7.08%), TGTX (-2.87%) and KRYS (-4.33%) all showed declines, broadly matching PTCT’s -1.23% move, but were not flagged by the momentum scanner as a coordinated sector move.

Historical Context

5 past events · Latest: Jan 12 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 12	Preliminary results, guide	Positive	+0.1%	Preliminary 2025 revenue and detailed 2026 guidance with Sephience contribution.
Jan 08	Inducement equity grant	Neutral	+0.9%	Small RSU inducement grant under Nasdaq Listing Rule 5635(c)(4).
Dec 22	Japan drug approval	Positive	+0.4%	Japanese approval for Sephience for PKU across all ages and severities.
Dec 19	Inducement equity grants	Neutral	+0.4%	Stock options and RSUs granted to new employees under Nasdaq inducement rules.
Dec 18	Conference presentation	Neutral	-0.5%	Announcement of J.P. Morgan Healthcare Conference presentation and webcast details.

Pattern Detected

Recent news, including product approvals, guidance, and conference updates, has generally been followed by modest price moves, usually under 1% in either direction.

Recent Company History

Over the past few months, PTC reported preliminary 2025 revenue of $823.4M with Sephience contributing $112.1M, and issued detailed 2026 guidance. The company also secured Japanese approval for Sephience in PKU and highlighted its story at the J.P. Morgan Healthcare Conference. Other updates focused on routine inducement grants. Price reactions to these items were small (within about 1%), suggesting measured trading responses to fundamental and corporate developments. Today’s earnings-date notice fits into this steady news cadence.

Market Pulse Summary

This announcement schedules the release of fourth quarter and full year 2025 results for Feb. 19, 20...

Analysis

This announcement schedules the release of fourth quarter and full year 2025 results for Feb. 19, 2026 at 4:30 p.m. ET, with a webcast and a 30-day replay. In context of recent preliminary revenue figures, 2026 guidance, and a new product approval in Japan, this sets a clear point for more detailed financial and strategic updates. Investors may watch for any changes versus the earlier unaudited numbers and guidance.

Key Terms

nasdaq

1 terms

nasdaq financial

"(NASDAQ: PTCT) announced today that the company will host a webcast"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

AI-generated analysis. Not financial advice.

WARREN, N.J., Feb. 5, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its fourth quarter and full year 2025 financial results and provide an update on the company's business and outlook on Thursday, Feb. 19, 2026, at 4:30 p.m. ET.

To access the call by phone, please click here to register and you will be provided with dial-in details. The webcast conference call can be accessed on the Investors section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be archived on the company's website for 30 days.

About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on LinkedIn, X, Facebook, and Instagram.

For more information, please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-thursday-feb-19-2026-302679246.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics (PTCT) report Q4 and full-year 2025 results?

PTC Therapeutics will report results on Thursday, Feb. 19, 2026 at 4:30 p.m. ET. According to PTC Therapeutics, the company will discuss fourth quarter and full year 2025 financial results and provide an update on business and outlook during the webcast conference call.

How can investors join the PTC Therapeutics (PTCT) Feb. 19, 2026 webcast conference call?

Investors can join via webcast on the company's Investors website or register for phone dial-in access. According to PTC Therapeutics, phone registrants will receive dial-in details and the webcast is available at the investor events and presentations page.

Will PTC Therapeutics (PTCT) make a replay of the Feb. 19, 2026 call available?

Yes. According to PTC Therapeutics, a replay of the webcast conference call will be archived on the company's website for 30 days. Investors can access the replay via the investor events and presentations page after the live call concludes.

What topics will PTC Therapeutics (PTCT) cover on the Feb. 19, 2026 call?

The company will report financial results and provide a business update and outlook. According to PTC Therapeutics, the webcast conference call will cover fourth quarter and full year 2025 financial results plus commentary on business performance and forward guidance.

Where is the PTC Therapeutics (PTCT) webcast hosted and how do I find it?

The webcast is hosted on the PTC Therapeutics Investors website at the events and presentations page. According to PTC Therapeutics, investors should visit the investor relations events page to access the live webcast and subsequent 30-day archived replay.